Literature DB >> 22214355

No evidence for a large difference in ALS frequency in populations of African and European origin: a population based study in inner city London.

Ricardo Rojas-Garcia1, Kirsten M Scott, Jose Carlos Roche, William Scotton, Naomi Martin, Anna Janssen, Laura H Goldstein, P Nigel Leigh, Cathy M Ellis, Christopher E Shaw, Ammar Al-Chalabi.   

Abstract

Abstract Previous studies have suggested a lower incidence of ALS in people of African origin. We used a population based register in an urban setting from inner city London postcodes where there is a large population of people of African ancestry to compare the frequency of ALS in people of European and African origin. Population statistics stratified by age, gender and ethnicity were obtained from the 2001 census. Incidence and prevalence were calculated in each ethnic group. Results showed that in a population of 683,194, of which 22% were of African ancestry, 88 individuals with ALS were identified over a seven-year period, including 14 people with African ancestry. The adjusted incidence in people of African ancestry was 1.35 per 100,000 person-years (95% CI 0.72-2.3) and in those of European ancestry 1.97 per 100,000 person-years (95% CI 1.55-2.48). In conclusion, in this small population based study we could not detect a difference in rates of ALS between people of African ancestry and those of European ancestry.

Entities:  

Mesh:

Year:  2012        PMID: 22214355     DOI: 10.3109/17482968.2011.636049

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  5 in total

Review 1.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

2.  Minorities, men, and unmarried amyotrophic lateral sclerosis patients are more likely to die in an acute care facility.

Authors:  Stephen A Goutman; Dustin G Nowacek; James F Burke; Kevin A Kerber; Lesli E Skolarus; Brian C Callaghan
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-06-12       Impact factor: 4.092

3.  Modulation of the lipidomic profile due to a lipid challenge and fitness level: a postprandial study.

Authors:  Ciara Morris; Colm M O'Grada; Miriam F Ryan; Michael J Gibney; Helen M Roche; Eileen R Gibney; Lorraine Brennan
Journal:  Lipids Health Dis       Date:  2015-07-01       Impact factor: 3.876

4.  Epidemiology of ALS in Korea using nationwide big data.

Authors:  Kyo Yeon Jun; Jinseok Park; Inah Kim; Seung Hyun Kim; Ki-Wook Oh; Eun Mi Kim; Jong Seok Bae
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-11-08       Impact factor: 10.154

Review 5.  Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis.

Authors:  Benoît Marin; Farid Boumédiene; Giancarlo Logroscino; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Massimilano Copetti; Pierre-Marie Preux; Ettore Beghi
Journal:  Int J Epidemiol       Date:  2017-02-01       Impact factor: 7.196

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.